Roche gets EC nod for Tecentriq and Avastin combo for first-line lung cancer

Image: Roche has secured approval in Europe for Tecentriq combo to treat metastatic non-squamous NSCLC. Photo: courtesy of F. Hoffmann-La Roche Ltd.